• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 5. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300

Introduction to (1-((3-Bromophenyl)sulfonyl)piperidin-4-yl)methanamine hydrochloride (CAS No. 1353958-71-0)

(1-((3-Bromophenyl)sulfonyl)piperidin-4-yl)methanamine hydrochloride, with the CAS number 1353958-71-0, is a specialized chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound belongs to a class of molecules known for their potential therapeutic applications, particularly in the modulation of biological pathways associated with neurological and cardiovascular diseases. The structural features of this molecule, including its piperidine ring and sulfonyl substituent, contribute to its unique pharmacological profile, making it a subject of intense study among medicinal chemists.

The< strong>piperidine core is a common scaffold in many bioactive molecules due to its ability to mimic the conformational flexibility of natural amino acids. In the case of (1-((3-Bromophenyl)sulfonyl)piperidin-4-yl)methanamine hydrochloride, the presence of a< strong>sulfonyl group attached to the piperidine ring enhances its interaction with biological targets. This modification has been shown to improve binding affinity and selectivity, which are critical factors in the design of effective drugs.

Recent research has highlighted the importance of< strong>3-bromophenyl derivatives in drug discovery. The bromine atom in this aromatic ring serves as a key pharmacophore, facilitating interactions with specific enzymes and receptors. Studies have demonstrated that compounds incorporating this moiety often exhibit potent activity against a range of therapeutic targets. The combination of these elements in (1-((3-Bromophenyl)sulfonyl)piperidin-4-yl)methanamine hydrochloride makes it a promising candidate for further investigation.

In the realm of medicinal chemistry, the development of new molecular entities often involves iterative optimization to enhance pharmacokinetic properties and reduce potential side effects. The< strong>methanamine moiety in this compound introduces a basic nitrogen atom, which can be exploited for salt formation, improving solubility and stability. The hydrochloride salt form of this compound, as indicated by its name, is likely chosen for these reasons, ensuring better bioavailability and shelf-life.

One of the most exciting aspects of (1-((3-Bromophenyl)sulfonyl)piperidin-4-yl)methanamine hydrochloride is its potential application in treating neurological disorders. Emerging evidence suggests that modulating certain neurotransmitter systems can have profound effects on cognitive function and mental health. The structural similarity of this compound to known active ingredients in neurotherapeutic drugs makes it an attractive candidate for further exploration. Researchers are particularly interested in its ability to interact with serotonin and dopamine receptors, which play crucial roles in mood regulation and cognitive processes.

The< strong>sulfonyl group has been extensively studied for its role in drug design due to its ability to form hydrogen bonds and participate in dipole-dipole interactions with biological targets. In (1-((3-Bromophenyl)sulfonyl)piperidin-4-yl)methanamine hydrochloride, this group is positioned strategically to engage with key residues on target proteins, enhancing binding affinity. This feature has been leveraged in the design of drugs targeting enzymes such as kinases and proteases, which are often implicated in various diseases.

Another area of interest is the potential use of (1-((3-Bromophenyl)sulfonyl)piperidin-4-yl)methanamine hydrochloride in cardiovascular research. Studies have shown that certain piperidine derivatives can influence blood pressure regulation and cholesterol metabolism. The presence of the< strong>3-bromophenyl moiety may contribute to these effects by modulating pathways involved in cardiovascular function. Further research is needed to fully elucidate these mechanisms and explore potential therapeutic applications.

The synthesis of (1-((3-Bromophenyl)sulfonyl)piperidin-4-yl)methanamine hydrochloride involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, have been employed to construct the complex framework of this molecule efficiently. These methods not only improve synthetic efficiency but also allow for greater control over stereochemistry, which is essential for biological activity.

In conclusion, (1-((3-Bromophenyl)sulfonyl)piperidin-4-yl)methanamine hydrochloride (CAS No. 1353958-71-0) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and promising biological activity. Its potential applications in treating neurological and cardiovascular diseases make it a valuable compound for further research and development. As our understanding of biological pathways continues to grow, compounds like this one will play an increasingly important role in the discovery of new therapies that improve human health.

• 214210-14-7(1-(3-Bromophenylsulfonyl)pyrrolidine)
• 120482-76-0(3,7-Diazabicyclo[3.3.1]nonane,3-[(4-bromophenyl)sulfonyl]-7-methyl-)
• 120482-72-6(3,7-Diazabicyclo[3.3.1]nonane,3-[(4-bromophenyl)sulfonyl]-9,9-dimethyl-7-pentyl-, hydrochloride (1:1))
• 834-66-2(1-(4-Bromophenylsulfonyl)piperidine)
• 871269-12-4(1-(3-Bromophenylsulfonyl)piperidine)
• 1353978-50-3(1-((3-Bromophenyl)sulfonyl)-N-methylpiperidin-4-amine hydrochloride)
• 1353952-00-7(3-Bromo-N-(piperidin-4-ylmethyl)benzenesulfonamide hydrochloride)
• 1353986-00-1((1-((3-Bromophenyl)sulfonyl)piperidin-3-yl)methanamine hydrochloride)
• 120466-20-8(Spiro[cyclohexane-1,9'-[3,7]diazabicyclo[3.3.1]nonane],3'-[(4-bromophenyl)sulfonyl]-7'-(cyclohexylmethyl)-)
• 153439-48-6(1-(4-Bromobenzene)sulfonylhomopiperidine)